Quality-of-Life Management for COPD Patients

Not Applicable

Completed

• Conditions: Copd; Chronic Respiratory Disease

• Registration Number: NCT04373070
• Lead Sponsor: University of Zurich

Brief Summary

The investigators aim to investigate the effects of a telemonitoring and chatbot-based application of "Living well with COPD" (CAir) on health-related quality-of-life in patients with COPD.

Detailed Description

The disease management programme "Living well with COPD" was developed to relieve symptoms and prevent exacerbations. It covers a disease self-management approach, educational topics, lifestyle coaching and physical activity advice.

Future implications should aim to make the intervention easily accessible for a broad spectrum of patients at scalable costs. Patients need an engaging communication platform which can inform, coach and even listen in between medical visits. The inclusion of a chatbot agent may provide this tailored feedback. The investogator's aim is to investigate the effects of a telemonitoring and chatbot-based application of "Living well with COPD" on health-related quality-of-life in patients with COPD.

Study Timeline

• Study First Submitted: 2020-04-24
• Study First Submitted QC: 2020-04-29
• Study First Posted: 2020-05-04
• Study Start: 2021-02-03
• Primary Completion: 2022-05-30
• Study Completion: 2022-05-30
• Status Verified: 2022-11
• Last Update Submitted: 2022-11-06
• Last Update Posted: 2022-11-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

• Diagnosed COPD according to GOLD-guidelines

Exclusion Criteria

• Physical or intellectual impairment precluding informed consent or protocol adherence
• Non-German speaking
• Acute or recent (within the last 6 weeks) exacerbation of COPD
• Attending a pulmonary rehabilitation program within the last 3 months
• Pregnant patients

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Health-related quality-of-life (HrQoL)	3 months	St. George Respiratory Questionnaire (SGRQ). Scoring: Scores range from 0 to 100, with higher scores indicating more limitations.

Secondary Outcome Measures

Name	Time	Method
Symptom burden	3 months	COPD Assessment Test (CAT). Scoring: Scores range from 0-40, with higher scores indicating more symptoms.
Spirometry	3 months	Forced vital capacity (FVC) in liters and percent predicted.
Accelerometry	3 months	Daily step count (number of steps)
Functional exercise capacity	3 months	One-minute sit-to-stand test (1MSTS) in repetitions performed.

Trial Locations

Locations (1)

University Hospital Zurich; 🇨🇭 Zurich, Switzerland